Tour De France 2026

On the morning of July 8, 1998, three days before the start of the Tour de France, a French customs officer at the Belgium-France border conducted a routine inspection of a car driven by Willy Voet, a soigneur for the Festina cycling team. The inspection produced what would become one of the most consequential cultural-political moments in the history of professional sport: 234 doses of erythropoietin (EPO), 60 doses of testosterone, 82 doses of human growth hormone, and various other performance-enhancing substances, all in quantities and combinations that made clear the materials were not for personal use. Voet was arrested. The Festina team was, within a few days, ejected from the Tour. The subsequent investigation produced criminal proceedings against multiple riders, team officials, and physicians, and a French parliamentary inquiry that became one of the most extensive public documentations of systemic doping in the history of the sport. The Festina affair, as it has been known since, broke a hundred-year-old silence about what professional cycling had been doing to itself, and the silence has, despite the affair's exposure and the subsequent twenty-seven years of anti-doping regulation, never fully been restored.

The current annual entry in the Cyanide cycling-simulation lineage, Tour de France 2026, releases in early June. The game's design has been refined across more than a decade of incremental annual updates: rider-fatigue modeling, team-tactics systems, mountain-stage difficulty curves, time-trial physics. The game has been working at the proposition that competitive cycling can be simulated in a video game that captures the actual experience of the sport. The proposition has been mostly successful within the limits the genre has accepted. The genre has not, across the lineage's history, asked the question the Festina affair forced into the open in 1998 and that the actual sport has been working not to answer since.

The frame this essay wants to give the reader is that the question is unavoidable for anyone willing to look at it carefully, and the question has implications well beyond cycling. The question is what counts as natural human athletic performance in a sport whose unaugmented version no one wants to watch. The cycling case is the clearest contemporary instance of a broader pattern that has been quietly developing in many domains of contemporary life: the recognition that the modern professional version of many activities exceeds what the unmodified human body or mind can deliver, the broader social acceptance of the modifications required, and the persistent cultural reluctance to acknowledge what is happening.

The physiological case for the unavoidability of the question is straightforward in the exercise-physiology literature. A three-week grand tour requires riders to sustain extraordinarily high power outputs across approximately twenty-one stages, with mountain stages exceeding six hours, with total cumulative distance over three thousand kilometers, and with recovery periods between stages that are, by any honest exercise-physiology accounting, inadequate. The peak power outputs that win mountain stages, the sustained climbing wattages required to stay with the leaders on the major ascents, and the cumulative cardiovascular load across the three weeks are, in the consensus of exercise physiologists working in the field, beyond what the unmodified human body can produce in the configurations required.

The historical record supports this. The cycling literature has documented, in patient detail, that some form of pharmacological enhancement has been part of professional cycling since approximately 1903, when the first Tour was raced. Henri Pélissier, the 1923 Tour winner, gave an interview in 1924 (the famous Forçats de la Route interview with the journalist Albert Londres) in which he and his brother Francis displayed what they were taking - strychnine, cocaine, chloroform, various stimulants - and explained that the sport was structurally impossible without them. The 1960 Tour produced the death of the Danish rider Knud Enemark Jensen, attributed to amphetamine use. The 1967 Tour produced the death of the British rider Tom Simpson on Mont Ventoux, with amphetamines found in his jersey pocket. The 1990s saw the EPO era, ended (in formal terms) by the Festina affair in 1998. The 2000s saw the continued use of EPO and the introduction of blood doping, documented in Tyler Hamilton's 2012 memoir The Secret Race and exhaustively confirmed by the USADA investigation that culminated in Lance Armstrong's 2012 confession to Oprah Winfrey. The 2010s saw the development of more sophisticated micro-dosing protocols designed to evade the biological-passport detection system. The 2020s have seen continued anti-doping enforcement and continued violations, with the specific substances and methods becoming more sophisticated as the testing improves.

The pattern across all twelve decades is consistent. The sport demands a level of performance the unmodified body cannot deliver. The riders, in pursuit of competitive viability, use what is available. The authorities periodically expose and punish the practices. The practices continue, in adapted forms, at the limits of what the current detection regime can identify. The cycling reader of this essay will have, on the available historical and contemporary evidence, no serious doubt that pharmacological enhancement remains a substantial feature of the contemporary professional sport, even when the specific substances and protocols are being actively concealed.

The political-philosophical question the persistence raises is what the Canadian sport scholars Rob Beamish and Ian Ritchie, in their 2006 Fastest, Highest, Strongest, called the high-performance contradiction. The contradiction is that contemporary elite sport demands performance levels that have moved beyond the unaugmented human body's capacities, while simultaneously maintaining a public-facing commitment to natural athletic excellence that the actual practice cannot deliver. The contradiction is not a temporary embarrassment that better enforcement will resolve; it is, on Beamish and Ritchie's argument, a structural feature of how elite sport has developed across the past century, and the contradiction will persist as long as the sport continues demanding the performance levels.

The standard responses to the contradiction have not been adequate to its scale. The anti-doping regulatory regime, established formally with the founding of the World Anti-Doping Agency in 1999 in the wake of the Festina affair, has been an extensive bureaucratic enterprise that has produced real reductions in some doping practices while failing to address the structural cause. The athlete-as-cheater framing, in which the riders who get caught are individual moral failures who have betrayed the sport, has been the dominant public narrative for the past two decades and has done substantial work to shift attention away from the structural conditions producing the practice. The technological-fix framing, in which better biological-passport monitoring and more sensitive testing will eventually eliminate the practice, has consistently underestimated the resources and ingenuity the riders, teams, and physicians bring to evading the testing.

What has been almost entirely absent from the public conversation about cycling doping is the question Beamish and Ritchie's framework actually raises: whether the sport should continue demanding the performance levels that the contradiction requires. This is a harder question because it points to a possibility no party in the sport has any incentive to take seriously. The sport, in its commercially-organized professional form, exists because audiences want to watch the performances the current demand levels produce. Reducing the demand levels would produce a different sport, watched by a smaller audience, generating less revenue, with shorter careers and lower compensation for the participants. The sport's current configuration is the configuration that emerged from the commercial pressures of professional cycling's twentieth-century development, and the configuration is not going to be revised by good-faith negotiation among the affected parties because all of the parties benefit from the current configuration in ways the alternative would not provide.

The cycling video game inherits this entire situation and quietly elides it. The Cyanide series' fatigue modeling, recovery systems, and team-tactics simulation are calibrated against the actual professional sport, which is to say they are calibrated against performances that the historical and ongoing evidence indicates are pharmacologically enhanced. The game does not, in any of its modes, ask the player to engage with the question of what the modeled performances actually require. The player races simulated riders at simulated wattages on simulated mountain stages, and the simulation works because it is calibrated to the actual performance data the contemporary professional sport produces. The data is what it is. The data's relationship to unenhanced performance is the question the simulation does not ask.

This is not, on a fair reading, the simulation's fault. The simulation is doing what cycling-simulation video games have done across the lineage. The simulation's silence on the question is the same silence the surrounding cultural conversation maintains about the sport. The conversation has been working not to ask the question for over a century. The simulation continues the silence in the medium that could, in principle, do more with it.

What an alternative cycling game could do, if one wanted to attempt it, is the kind of design experiment the medium has been resistant to. A cycling simulation that included, as part of the game's systems, the actual physiological costs and benefits of various pharmacological options would be doing the kind of unflinching simulation work that the genre has avoided. The player would be asked to make the decisions the actual riders make - to accept the marginal performance gain that the substance offers, with the medical risks and the legal risks the riders accept - and the game's systems would model the consequences honestly. This is an uncomfortable design proposition, and no commercial cycling game has, on the available record, attempted it. The discomfort is the substance of why the proposition has not been attempted.

The broader cultural implication extends well past cycling. The high-performance contradiction Beamish and Ritchie identified is present, in varying forms, across many contemporary domains. Professional musicianship requires technical skill levels that, in the orchestral and classical world, are increasingly impossible to sustain without the beta-blockers that have become near-universal among performers managing audition-anxiety. Contemporary chess at the elite level has produced documented use of cognitive-enhancing substances. The contemporary financial sector's documented use of stimulants and cognitive enhancers is an open secret in the relevant professional communities. The contemporary academic-research and writing world has seen substantial documented use of cognitive enhancers among graduate students and faculty. The technology sector's microdosing-of-psychedelics culture has been the subject of considerable journalistic coverage. The military's authorized use of cognitive enhancers in combat-pilot operations has been continuous since the Second World War.

In each of these cases, the same basic pattern holds. The activity, in its current professional form, demands performance levels that the unaugmented human body and mind have substantial difficulty sustaining. The participants, in pursuit of competitive viability, use what is available. The institutional response is a varying mixture of denial, prohibition, selective enforcement, and quiet accommodation. The public conversation is mostly absent because no party with influence wants to have it.

Michael Sandel, the Harvard philosopher whose 2007 The Case Against Perfection attempted to develop a principled framework for thinking about performance enhancement across multiple domains, argued that the question turns on what he called the givenness of human capacities. Sandel's position was that the cultural value of athletic, musical, intellectual, and other accomplishment depends in part on the recognition that the accomplishment emerges from the given limits of the human body and mind. The accomplishment that has been engineered around the limits, on Sandel's argument, is not equivalent to the accomplishment that has worked within them. The two accomplishments may produce similar measurable results, but the cultural meaning of the result differs.

The argument is contestable. The philosopher Andy Miah, in his 2004 Genetically Modified Athletes, made the opposing case: the categories of natural and enhanced performance have been culturally constructed, the line between training and enhancement has always been ambiguous, the contemporary anti-doping framework is incoherent on its own terms, and the more honest response is to acknowledge that contemporary high-performance human activity is augmented activity and to develop the regulatory and cultural frameworks that allow the augmentation to be conducted safely. Miah's position is in the minority among contemporary sport-ethics scholars but has been gaining ground as the practical evidence accumulates that the prohibitionist framework is not, in fact, eliminating the practice.

What the cycling video game's silence on the question reflects is not a moral failure of the simulation; it is the broader cultural failure to have the conversation. The simulation cannot ask the question because the surrounding cultural conditions have not produced the vocabulary in which the question could be asked. The simulation's contribution to the cultural-political situation, intentional or not, is to continue the silence by modeling the current performance levels as if they were the natural ones. The audience that plays the game receives, in implicit form, the message that the modeled performances are what cycling looks like, without any of the questions about what makes the performances possible.

The reader who finishes this essay, before opening Tour de France 2026 or any of its successors, can carry the small recognition that the modeled performances are not innocent. The simulation is, in the strict cognitive register, training the player to expect the contemporary professional sport as the baseline against which any specific race should be evaluated. The training is identical to the training the actual sport has been providing its spectators across the past century. The training is, on the available evidence, calibrated against performance levels that pharmaceutical enhancement is a substantial part of producing. The simulation continues the silence the surrounding sport has been maintaining. The reader is now in a position to notice the silence even when the simulation does not name it.

The next pharmacological scandal in professional cycling will arrive sometime in the next several years. The pattern across the past century guarantees that it will. The cycling game released the same year as the scandal will continue modeling the performances the riders just got caught producing, with no acknowledgment in the simulation's design of what producing the performances actually required. The silence will continue. The contradiction Beamish and Ritchie identified in 2006 will continue. The question of what the sport asks of the people inside it, and of what the modeled performance levels the audience has come to expect actually depend on, will continue to be the question the contemporary culture of professional sport works hardest not to answer.